methoxyhydroxyphenylglycol has been researched along with Heart Failure, Systolic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujimoto, T; Kakinoki, S; Machida, M; Nomura, A; Takechi, S | 1 |
1 trial(s) available for methoxyhydroxyphenylglycol and Heart Failure, Systolic
| Article | Year |
|---|---|
Carvedilol improves uptake-1 in patients with systolic congestive heart failure.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Carbazoles; Carvedilol; Exercise Test; Female; Heart Failure, Systolic; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Propanolamines; Sympathetic Nervous System; Treatment Outcome | 2012 |